GRL-0667, Noncovalent inhibitor of SARS-CoV PLpro, 25mg, CAS# 1234195-91-5

GRL-0667, Noncovalent inhibitor of SARS-CoV PLpro, 25mg, CAS# 1234195-91-5

Jun9-72-2, SARS-CoV-2 papain-like protease (PLpro) inhibitor, 25mg, CAS# 2657659-42-0

Jun9-72-2, SARS-CoV-2 papain-like protease (PLpro) inhibitor, 25mg, CAS# 2657659-42-0

GRL-0617, SARS-CoV PLpro inhibitor, 25mg, CAS# 1093070-16-6

$250.00
5-Amino-2-methyl-N-(1R-naphthalen-1-yl-ethyl)benzamide Purity: 99% by HPLC NMR (Conforms) Store -20°C Ship RT (1 per EA )

Manufacturer: Focus Biomolecules

SKU
10-4965-25mg-EA
GRL-0617, SARS-CoV PLpro inhibitor, 25mg, CAS# 1093070-16-6 is available to buy in increments of 1

Product Details

Download Details and Specifications

GRL-0617 is a potent (IC50 = 600 nM) noncovalent inhibitor of severe acute respiratory syndrome-coronavirus papain-like protease (SARS-CoV PLpro). GRL0617 inhibited SARS-CoV viral replication in Vero E6 cells with no cytotoxicity (EC50 = 15 µM). Inactive against human DUB-like proteases HAUSP, USP18, UCH-L1, UCH-L3, and PLP2.

CAS Number: 1093070-16-6

Manufacturer Part Number/SKU: 10-4965-25mg-EA

Tags: Focus Biomolecules